Enhancing Natural Killer Cell-Mediated Lysis of Lymphoma Cells by Combining Therapeutic Antibodies With CD20-Specific Immunoligands Engaging NKG2D or NKp30

Blood- United States

doi 10.1182/blood.v124.21.1779.1779

Full Text

Abstract

Available in

Date

Authors

Publisher

American Society of Hematology

Related search

Reactive Oxygen Species Induced by Therapeutic CD20 Antibodies Inhibit Natural Killer Cell-Mediated Antibody-Dependent Cellular Cytotoxicity Against Primary CLL Cells

Oncotarget
Oncology
2016English

Oncogenicity of Human Papillomavirus- Or Adenovirus-Transformed Cells Correlates With Resistance to Lysis by Natural Killer Cells.

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
1995English

Human microRNA-1245 Down-Regulates the NKG2D Receptor in Natural Killer Cells and Impairs NKG2D-mediated Functions

Haematologica
Hematology
2012English

Deficient Natural Killer Cell NKp30-mediated Function and Altered NCR3 Splice Variants in Hepatocellular Carcinoma

Hepatology
MedicineHepatology
2019English

TLR8 Stimulation Enhances Cetuximab-Mediated Natural Killer Cell Lysis of Head and Neck Cancer Cells and Dendritic Cell Cross-Priming of EGFR-specific CD8+ T Cells

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2013English

The Requirement for DNAM-1, NKG2D, and NKp46 in the Natural Killer Cell-Mediated Killing of Myeloma Cells

Cancer Research
Cancer ResearchOncology
2007English

Natural Killer P30 Receptor (NKp30; NCR3; CD337)

Science-Business eXchange
2013English

NKG2D Signaling Leads to NK Cell Mediated Lysis of Childhood AML

Journal of Immunology Research
MedicineAllergyImmunology
2015English

Nasal Natural Killer/T Cell Lymphoma

Indian Journal of Hematology and Blood Transfusion
Hematology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy